Annual FCF
-$33.38 M
+$10.83 M+24.49%
December 31, 2023
Summary
- As of February 8, 2025, HOWL annual free cash flow is -$33.38 million, with the most recent change of +$10.83 million (+24.49%) on December 31, 2023.
- During the last 3 years, HOWL annual FCF has fallen by -$14.20 million (-74.00%).
- HOWL annual FCF is now -240.34% below its all-time high of -$9.81 million, reached on December 31, 2019.
Performance
HOWL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$12.46 M
+$1.73 M+12.18%
September 30, 2024
Summary
- As of February 8, 2025, HOWL quarterly free cash flow is -$12.46 million, with the most recent change of +$1.73 million (+12.18%) on September 30, 2024.
- Over the past year, HOWL quarterly FCF has dropped by -$5.04 million (-67.79%).
- HOWL quarterly FCF is now -781.54% below its all-time high of -$1.41 million, reached on June 30, 2022.
Performance
HOWL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$46.85 M
-$5.04 M-12.04%
September 30, 2024
Summary
- As of February 8, 2025, HOWL TTM free cash flow is -$46.85 million, with the most recent change of -$5.04 million (-12.04%) on September 30, 2024.
- Over the past year, HOWL TTM FCF has dropped by -$5.86 million (-14.31%).
- HOWL TTM FCF is now -1117.52% below its all-time high of -$3.85 million, reached on March 31, 2020.
Performance
HOWL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
HOWL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +24.5% | -67.8% | -14.3% |
| 3 y3 years | -74.0% | -0.6% | -6.0% |
| 5 y5 years | -240.3% | -0.6% | -6.0% |
HOWL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.5% | -781.5% | +24.1% | -40.4% | +6.3% |
| 5 y | 5-year | -240.3% | +24.5% | -781.5% | +24.1% | -1117.5% | +6.3% |
| alltime | all time | -240.3% | +24.5% | -781.5% | +24.1% | -1117.5% | +6.3% |
Werewolf Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$12.46 M(-12.2%) | -$46.85 M(+12.0%) |
| Jun 2024 | - | -$14.19 M(-7.9%) | -$41.81 M(+8.0%) |
| Mar 2024 | - | -$15.41 M(+222.1%) | -$38.72 M(+16.0%) |
| Dec 2023 | -$33.38 M(-24.5%) | -$4.78 M(-35.6%) | -$33.38 M(-18.6%) |
| Sep 2023 | - | -$7.43 M(-33.1%) | -$40.99 M(-18.0%) |
| Jun 2023 | - | -$11.10 M(+10.3%) | -$49.98 M(+24.0%) |
| Mar 2023 | - | -$10.07 M(-18.7%) | -$40.29 M(-8.9%) |
| Dec 2022 | -$44.21 M | -$12.39 M(-24.6%) | -$44.21 M(-1.2%) |
| Sep 2022 | - | -$16.43 M(+1061.7%) | -$44.76 M(+9.6%) |
| Jun 2022 | - | -$1.41 M(-89.9%) | -$40.86 M(-18.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.98 M(+8.0%) | -$50.01 M(+15.3%) |
| Dec 2021 | -$43.37 M(+126.1%) | -$12.95 M(+3.4%) | -$43.37 M(+19.0%) |
| Sep 2021 | - | -$12.52 M(+18.4%) | -$36.45 M(+26.1%) |
| Jun 2021 | - | -$10.57 M(+44.0%) | -$28.91 M(+27.5%) |
| Mar 2021 | - | -$7.34 M(+22.0%) | -$22.68 M(+18.2%) |
| Dec 2020 | -$19.18 M(+95.6%) | -$6.02 M(+20.9%) | -$19.18 M(+45.7%) |
| Sep 2020 | - | -$4.98 M(+14.7%) | -$13.17 M(+60.8%) |
| Jun 2020 | - | -$4.34 M(+12.8%) | -$8.19 M(+112.8%) |
| Mar 2020 | - | -$3.85 M | -$3.85 M |
| Dec 2019 | -$9.81 M | - | - |
FAQ
- What is Werewolf Therapeutics annual free cash flow?
- What is the all time high annual FCF for Werewolf Therapeutics?
- What is Werewolf Therapeutics annual FCF year-on-year change?
- What is Werewolf Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Werewolf Therapeutics?
- What is Werewolf Therapeutics quarterly FCF year-on-year change?
- What is Werewolf Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Werewolf Therapeutics?
- What is Werewolf Therapeutics TTM FCF year-on-year change?
What is Werewolf Therapeutics annual free cash flow?
The current annual FCF of HOWL is -$33.38 M
What is the all time high annual FCF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high annual free cash flow is -$9.81 M
What is Werewolf Therapeutics annual FCF year-on-year change?
Over the past year, HOWL annual free cash flow has changed by +$10.83 M (+24.49%)
What is Werewolf Therapeutics quarterly free cash flow?
The current quarterly FCF of HOWL is -$12.46 M
What is the all time high quarterly FCF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high quarterly free cash flow is -$1.41 M
What is Werewolf Therapeutics quarterly FCF year-on-year change?
Over the past year, HOWL quarterly free cash flow has changed by -$5.04 M (-67.79%)
What is Werewolf Therapeutics TTM free cash flow?
The current TTM FCF of HOWL is -$46.85 M
What is the all time high TTM FCF for Werewolf Therapeutics?
Werewolf Therapeutics all-time high TTM free cash flow is -$3.85 M
What is Werewolf Therapeutics TTM FCF year-on-year change?
Over the past year, HOWL TTM free cash flow has changed by -$5.86 M (-14.31%)